Acquisition Rocks CMO Supply Chain Landscape
The news of the Novo Nordisk (Novo Holdings) intent to acquire Catalent has taken the industry by storm. It is unprecedented and shifts the risk…
Insightful Thought Leadership
The news of the Novo Nordisk (Novo Holdings) intent to acquire Catalent has taken the industry by storm. It is unprecedented and shifts the risk…
Sooner or later, every biotech, pharma or medical device company will face an audit. Use this general checklist to evaluate your organization and take proactive…
Addressing quality requirements of an investigational medicinal product for a given clinical trial without sharing your company’s overall development strategy for a medicinal product is…
Risk Framing and Conflict Mitigation Strategies in the Ukrainian Crisis The Windshire Group’s clients are facing unprecedented challenges to their supply chains from pandemics to…
Dr. James Blackwell, Ph.D, M.B.A discusses how the COVID-19 pandemic has caused significant changes, both disruptions and accelerated development. Lessons learned can inform practices from the…
"The following is an edited excerpt taken from The Windshire Group’s webcast Quality in the Laboratory: It’s in the Details Live Free Webcast Expert Panel Discussion…
The following is an edited excerpt taken from The Windshire Group’s webcast Validation: Tried and True Success Lessons from the Front Lines Expert Panel Discussion-LIVE FREE…
The following is an excerpt taken from The Windshire Group’s webcast “Conducting Proper Deviation Investigations Expert Panel Discussion – Live FREE Webcast”. Daniel DeLucy: Deviation investigations are a…
The following is an excerpt taken from The Windshire Group's webcast "Implementing a Change Control Quality System Successfully Expert Panel Discussion - Live FREE Webcast".…
The following is an excerpt taken from The Windshire Group’s webcast “Cell Therapy Expert Panel Discussion”: Dr. James Blackwell: It will not be business as usual. Sloppy…